Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Scodes

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Community Mental Health Journal|January 4, 2022
Feasibility and Utility of Different Approaches to Violence Risk Assessment for Young Adults Receiving Treatment for Early PsychosisStephanie A Rolin, Jennifer Scodes, Renald Dambreville, et al.
Schizophrenia Research|June 10, 2020
Trajectories of occupational and social functioning in people with recent-onset non-affective psychosis enrolled in specialized early intervention services across New York stateEls van der Ven, Jennifer Scodes, Cale Basaraba, et al.
Frontiers in Physiology|September 11, 2023
Cardiovascular variability, sociodemographics, and biomarkers of disease: the MIDUS studyTara Gruenewald, Teresa E Seeman, Tse-Hwei Choo, et al.
Alcoholism, Clinical and Experimental Research|September 12, 2018
Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General PopulationJustin Knox, Melanie Wall, Katie Witkiewitz, et al.
Journal of Addiction Medicine|October 3, 2023
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use DisorderMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Drug and Alcohol Dependence|March 11, 2019
Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general populationJustin Knox, Jennifer Scodes, Melanie Wall, et al.
Drug and Alcohol Dependence|November 10, 2019
Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxoneLesia M Ruglass, Jennifer Scodes, Martina Pavlicova, et al.
Drug and Alcohol Dependence|June 8, 2019
Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general populationJustin Knox, Melanie Wall, Katie Witkiewitz, et al.
The Lancet. Psychiatry|May 1, 2017
Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general populationDeborah S Hasin, Melanie Wall, Katie Witkiewitz, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Community Mental Health Journal|January 4, 2022
Feasibility and Utility of Different Approaches to Violence Risk Assessment for Young Adults Receiving Treatment for Early PsychosisStephanie A Rolin, Jennifer Scodes, Renald Dambreville, et al.
Schizophrenia Research|June 10, 2020
Trajectories of occupational and social functioning in people with recent-onset non-affective psychosis enrolled in specialized early intervention services across New York stateEls van der Ven, Jennifer Scodes, Cale Basaraba, et al.
Frontiers in Physiology|September 11, 2023
Cardiovascular variability, sociodemographics, and biomarkers of disease: the MIDUS studyTara Gruenewald, Teresa E Seeman, Tse-Hwei Choo, et al.
Alcoholism, Clinical and Experimental Research|September 12, 2018
Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General PopulationJustin Knox, Melanie Wall, Katie Witkiewitz, et al.
Journal of Addiction Medicine|October 3, 2023
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use DisorderMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Drug and Alcohol Dependence|March 11, 2019
Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general populationJustin Knox, Jennifer Scodes, Melanie Wall, et al.
Drug and Alcohol Dependence|November 10, 2019
Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxoneLesia M Ruglass, Jennifer Scodes, Martina Pavlicova, et al.
Drug and Alcohol Dependence|June 8, 2019
Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general populationJustin Knox, Melanie Wall, Katie Witkiewitz, et al.
The Lancet. Psychiatry|May 1, 2017
Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general populationDeborah S Hasin, Melanie Wall, Katie Witkiewitz, et al.
Pageof 5